Companies / Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc.

OTC: LYRACIK 1327273WATERTOWN, MA

Financials · FY2025

Revenue$398.0K
Net income$-28.92M
Total debt—
Cash$15.89M
Diluted EPS$-18.62
Shares outstanding1.8M

Ownership

1.8M shares outstanding · as of Mar 27, 2026
90.9%Insiders
Ownership
Insiders90.86%1,612,613
Institutions13.67%242,688
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Palasis MariaPrincipal Executive Officer · Director
61.68%1,094,733
Cavalier JasonPrincipal Financial Officer
29.18%517,880
Smith W BradfordDirector
0.00%0

Institutional holders 24

View all →
HolderValue% of shares
Sabby Management, LLC$539.5K9.87%
Ikarian Capital, LLC$65.2K1.19%
DRW Securities, LLC$51.8K0.95%
Geode Capital Management, LLC$37.7K0.69%
Artia Global Partners LP$27.0K0.49%
BlackRock, Inc.$7.4K0.13%
Tower Research Capital LLC (TRC)$6.7K0.12%
Royal Bank of Canada$6.0K0.11%
UBS Group AG$2.1K0.04%
EverSource Wealth Advisors, LLC$1.0K0.02%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 6, 2026Palasis Maria
Executive
SellCommon Stock$5.7K-2K
-0.15%
1,096,733
61.79% of shares
low
Jan 6, 2026Cavalier Jason
Executive
SellCommon Stock$2.6K-769
-0.15%
518,547
29.22% of shares
low
Apr 1, 2026Palasis Maria
Executive
OtherCommon Stock$0-2K
-0.18%
1,094,733
61.68% of shares
low
Apr 1, 2026Cavalier Jason
Executive
OtherCommon Stock$0-667
-0.13%
517,880
29.18% of shares
low
May 14, 2026Smith W Bradford
Director
OtherCommon Stock$0-640
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Sabby Management, LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LYRACommon StockEquity55234L204BBG001J2N202